Endocrine Abstracts

Glucocorticoids (GCs) are used to treat inflammatory diseases because they downregulate expression of numerous inflammatory mediators. This is at least partly achieved through functional interference of the glucocorticoid receptor (GR) with transcription factors such as NF-κB (transrepression). On the other hand, activation of transcription by GR is responsible for some of the side effects of GCs. Efforts to improve the safety profile of GCs are focused on the identificat...

The glucocorticoid (GC) activating enzyme 11β-HSD1 is potently upregulated within macrophages and synovial fibroblasts of inflamed joints, where it increases therapeutic GC signalling and regulates their anti-inflammatory profiles. Whilst in vitro studies have demonstrated the importance of autocrine signalling in this context, the importance of paracrine signalling remains poorly defined. In this study, we examined the role of 11β-HSD1 in paracrine GC signalling bet...